Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study.

Charlie Yue WangSophia ZoungasMabel YanRory WolfeAndrew HaydonMark ShackletonMark VoskoboynikMaggie MooreMiles C AndrewsStephen J NichollsVictoria Mar

Published in: Cardio-oncology (London, England) (2022)

Patients with high-risk or advanced melanoma are at an increased risk of atherosclerotic cardiovascular events following ICI treatment, particularly those with a history of cardiovascular disease.

Keyphrases

cardiovascular events
cardiovascular disease
coronary artery disease
skin cancer
type diabetes
metabolic syndrome
combination therapy
replacement therapy
smoking cessation